Market Overview

My goal is to be on stage with my computer and let you
see my screen and make sure you know what buttons to
press, where you’re getting in & out, how to calculate
risk, your targets — all of those things.
It’s real-life trading. Make sure you sign up!
- Jerremy Newsome

Sarepta, T-Mobile Make Moves After-Hours Following Earnings Results


We're officially in the doldrums of summer with some of the lowest volatility in over a decade, yet the market continues to hit new record highs.

Wednesday's after-hours session saw a host of big names release earnings.

T-Mobile US Inc (NASDAQ: TMUS) reported a second-quarter sales beat of $10.2 billion, beating analyst estimates by $390 million. Earnings came in at 67 cents per share. Net additions in the second quarter were 1.3 million and the telecom provider raised its FY17 EBITDA outlook from $10.4-10.8 billion to $10.5-$10.9 billion. Shares were up over 3 percent after hours.

QUALCOMM, Inc. (NASDAQ: QCOM) reported a 40 percent profit slump as it remains embroiled in a patent battle with Apple Inc (NASDAQ: AAPL). The company delivered Q3 adj. EPS of 83 cents beating estimates by 2 cents. Qualcomm managed to beat sales estimates by $140 million with revenues of $5.4 billion. Fourth quarter earnings forecasted in the 75-85 cents range against a 90-cent estimate. Shares were trading down over 2 percent after hours.

Alcoa Corp (NYSE: AA) shares were down over 2 percent after reporting a sizeable second quarter sales miss of $527 million, with $2.323 billion in revenues. Second-quarter earnings came in at 62 cents per share, beating estimates by 2 cents. The company raised its FY17 forecast for global aluminum demand growth from 4.5-5 percent to 4.75-5.25 percent.

American Express Company (NYSE: AXP) briefly hit a 52-week high after releasing a second-quarter earnings beat, with EPS coming in at $1.47, topping estimates by 3 cents. Sales came in $100 million higher than estimates at $8.3 billion. The company said it's confident it will remove $1B from its cost base on run rate basis by the years end.

Sarepta Therapeutics Inc (NASDAQ: SRPT) soared 15 percent after it delivered a smaller-than-expected earnings miss. EPS came in at a loss of 46 cents, beating estimates by 45 cents. Sales came in at $35 million, beating estimates by $12.6 million. Management raised FY17 sales outlook to $125-130 million.

Posted-In: Alcoa American Express Qualcomm SareptaEarnings News After-Hours Center Movers


Related Articles (AAPL + AA)

View Comments and Join the Discussion!

Watch These 8 Huge Call Purchases In Thursday Trade

Made In America By People From Abroad; Administration Boosts Migrant Worker Visas